Submission delayed by U.S. government shutdown; initial FDA questions expected during Q4 2025 "The Pivot submission is an exciting milestone in our mission to deliver a differentiated tubeless patch ...

The GLP-1 receptor agonist tirzepatide (Zepbound, Mounjaro) surpassed the cancer immunotherapy drug pembrolizumab (Keytruda) as the world's best-selling medicine. (STAT) An Institute for Clinical and ...

With the new school year well underway, provincial governments are implementing new health and safety policies, including classroom cellphone bans and requirements for automated external ...